Effect of UDCA, Sucralfate, and PPI Treatments and Gallbladder Pathologies on Duodenogastric Reflux Gastritis: A Retrospective Study

Background/Objectives: Duodenogastric reflux (DGR) gastritis remains a clinically challenging condition with limited comparative evidence regarding commonly used medical treatments and no well-established therapeutic strategy. This study aimed to compare symptomatic responses to different treatment regimens (PPI, PPI + sucralfate, PPI + UDCA) and to examine associations of gallbladder status with symptoms and histopathological findings in patients diagnosed with DGR. Methods: A total of 77 patients diagnosed with DGR in our endoscopy unit were retrospectively evaluated. Patients were divided into three groups: Group 1 (PPI + sucralfate, n = 32), Group 2 (PPI + UDCA, n = 31), and Group 3 (PPI, n = 14). Symptom scores were assessed before and after 6 weeks of treatment using a modified Likert scale. Histopathological parameters and symptoms were also evaluated according to gallbladder status (normal, gallstone, cholecystectomy). In 16 patients who underwent follow-up endoscopy, biopsy results before and after treatment were compared. Results: All three treatment groups showed significant within-group reductions in symptom scores after 6 weeks of therapy (all p < 0.01). However, the magnitude of symptom improvement did not differ significantly among treatment groups (p = 0.457). Symptom scores also decreased significantly within each gallbladder-status group, without a significant between-group difference. In the 16 patients with paired biopsies, no histopathological outcome showed a statistically significant change on two-sided exact Wilcoxon testing (activation p = 0.078; inflammation p = 0.094; intestinal metaplasia p = 0.625; H. pylori grade p = 0.307); these exploratory results were unadjusted for multiple comparisons. Conclusions: PPI, PPI + sucralfate, and PPI + UDCA regimens were each associated with significant short-term symptomatic improvement in patients with DGR; however, no statistically significant between-group difference was detected. Gallbladder status was not significantly associated with the magnitude of symptomatic improvement. The histopathological findings from the limited follow-up endoscopy subgroup should be interpreted as exploratory and require confirmation in larger prospective studies. By comparatively evaluating three commonly used medical treatment approaches together with gallbladder status within the same real-world cohort, this study provides additional clinical evidence in an area where comparative treatment data remain limited.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-18
DOI
https://doi.org/10.3390/healthcare14223964
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of UDCA, Sucralfate, and PPI Treatments and Gallbladder Pathologies on Duodenogastric Reflux Gastritis: A Retrospective Study

Mertcan Akçay, Yasin Alper Yıldız
Healthcare
Helicobacter pylori-related gastroenterology studies
article

Effect of UDCA, Sucralfate, and PPI Treatments and Gallbladder Pathologies on Duodenogastric Reflux Gastritis: A Retrospective Study

Mertcan Akçay, Yasin Alper Yıldız
article en

Abstract

Background/Objectives: Duodenogastric reflux (DGR) gastritis remains a clinically challenging condition with limited comparative evidence regarding commonly used medical treatments and no well-established therapeutic strategy. This study aimed to compare symptomatic responses to different treatment regimens (PPI, PPI + sucralfate, PPI + UDCA) and to examine associations of gallbladder status with symptoms and histopathological findings in patients diagnosed with DGR. Methods: A total of 77 patients diagnosed with DGR in our endoscopy unit were retrospectively evaluated. Patients were divided into three groups: Group 1 (PPI + sucralfate, n = 32), Group 2 (PPI + UDCA, n = 31), and Group 3 (PPI, n = 14). Symptom scores were assessed before and after 6 weeks of treatment using a modified Likert scale. Histopathological parameters and symptoms were also evaluated according to gallbladder status (normal, gallstone, cholecystectomy). In 16 patients who underwent follow-up endoscopy, biopsy results before and after treatment were compared. Results: All three treatment groups showed significant within-group reductions in symptom scores after 6 weeks of therapy (all p < 0.01). However, the magnitude of symptom improvement did not differ significantly among treatment groups (p = 0.457). Symptom scores also decreased significantly within each gallbladder-status group, without a significant between-group difference. In the 16 patients with paired biopsies, no histopathological outcome showed a statistically significant change on two-sided exact Wilcoxon testing (activation p = 0.078; inflammation p = 0.094; intestinal metaplasia p = 0.625; H. pylori grade p = 0.307); these exploratory results were unadjusted for multiple comparisons. Conclusions: PPI, PPI + sucralfate, and PPI + UDCA regimens were each associated with significant short-term symptomatic improvement in patients with DGR; however, no statistically significant between-group difference was detected. Gallbladder status was not significantly associated with the magnitude of symptomatic improvement. The histopathological findings from the limited follow-up endoscopy subgroup should be interpreted as exploratory and require confirmation in larger prospective studies. By comparatively evaluating three commonly used medical treatment approaches together with gallbladder status within the same real-world cohort, this study provides additional clinical evidence in an area where comparative treatment data remain limited.

HealthcareVol. 14(22)
Kastamonu Education and Research Hospital (TR), Kastamonu University (TR)
Good health and well-being
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon